Study: Ibuprofen reduces risk of Alzheimer’s disease
May 07, 2008
Study subjects who took ibuprofen for at least five years registered a 40% lower risk of developing Alzheimer’s disease, according to new research. Some medicines in the same non-steroidal anti-inflammatory...
Alzheimer’s-detecting PET scans could be on the market within a year
Jun 08, 2011
Nuclear medicine experts say positron emission tomography (PET) scans that detect beta amyloid plaques in the brain could make it to the marketplace within the next year. Beta-amyloid is a naturally occurring...
Geriatrics study: Drink your way to mental health… sort of
Jul 14, 2009
The largest study to date on the effects of alcohol intake among seniors has turned up mixed results: On one hand, moderate consumption significantly decreases the risk of developing dementia. However,...
Chance of a senior developing Alzheimer’s has dropped 44% over the last three decades, large U.S....
By
Tim Mullaney
Jul 16, 2014
The odds of developing Alzheimer’s disease fell sharply among seniors in the United States over the last 30 years, according to research presented Tuesday at the Alzheimer’s Association International...
Come on, just diagnose it
By
Jacqueline Vance, RNC, CDONA/LTC
Jun 07, 2022
For some reason, it seems like practitioners run away from diagnosing people with Alzheimer’s disease. I don’t understand that when, in fact, Alzheimer’s disease accounts for 75% to 80% of all dementias. ...
Medicare’s plan to cover Alzheimer’s drugs hinges on patient data registries
By
Alicia Lasek
Jun 02, 2023
Medicare Part B will cover Alzheimer’s drugs with traditional FDA approval, CMS announced Thursday. Prescribing clinicians must participate in a patient data registry.
Expanded role for Alzheimer’s medications?
Mar 14, 2012
Aricept and Namenda are typically used in the treatment of early-stage Alzheimer’s disease. They might also be helpful as the disease progresses, according to British investigators. Researchers found...
CMS to weigh national Medicare coverage for Aduhelm, other Alzheimer’s drugs
By
Alicia Lasek
Jul 14, 2021
The agency is considering whether to establish a national coverage policy for monoclonal antibody drugs that treat Alzheimer’s disease, including the newly approved drug aducanumab (Aduhelm).
Late-onset Alzheimer’s disease may be less aggressive, harder to detect
Aug 06, 2012
Alzheimer’s disease appears to progress more slowly in adults over 80, investigators have found. As a result, this type of late-onset Alzheimer’s disease may be more difficult to detect and...
New report highlights need for Alzheimer’s research
By
John Hall
Feb 09, 2015
A new report has compelled one of the leading advocates for Alzheimer’s research in the U.S. Senate to renew a call on the federal government to significantly boost research funding for the disease,...